Page last updated: 2024-08-18

4-butyrolactone and Bone Loss, Osteoclastic

4-butyrolactone has been researched along with Bone Loss, Osteoclastic in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, W; Li, B; Li, J; Liao, S; Lin, C; Liu, Y; Ou, L; Wang, D; Yao, J; Zhao, G; Zhao, J	1
Hsiao, HB; Lin, H; Lin, WC; Wu, JB	1

Other Studies

2 other study(ies) available for 4-butyrolactone and Bone Loss, Osteoclastic

Article	Year
Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression. Journal of cellular biochemistry, 2019, Volume: 120, Issue:11 Topics: 4-Butyrolactone; Angelica sinensis; Animals; Animals, Newborn; Bone Resorption; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Macrophages; Male; Mice, Inbred C57BL; Molecular Structure; Osteoblasts; Osteoclasts; Osteogenesis; RANK Ligand; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction	2019
Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:5 Topics: 4-Butyrolactone; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred ICR; Monosaccharides; NF-kappa B; Osteoclasts; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; X-Ray Microtomography	2013

Article

Year

Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression.

Journal of cellular biochemistry, 2019, Volume: 120, Issue:11

Topics: 4-Butyrolactone; Angelica sinensis; Animals; Animals, Newborn; Bone Resorption; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Macrophages; Male; Mice, Inbred C57BL; Molecular Structure; Osteoblasts; Osteoclasts; Osteogenesis; RANK Ligand; Rats, Sprague-Dawley; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction

2019

Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:5

Topics: 4-Butyrolactone; Animals; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Mice; Mice, Inbred ICR; Monosaccharides; NF-kappa B; Osteoclasts; Osteoporosis; Ovariectomy; RANK Ligand; Rats; Rats, Wistar; X-Ray Microtomography

2013